Pioneering microbiome science for
Dr. Alessio Fasano
Seed Health Scientific Board
We are at the dawn of a new scientific revolution. Our understanding of how to treat and prevent diseases has been transformed by knowledge of the microbiome—the rich ecosystem of microorganisms in and on every human. These microbial hitchhikers may hold the keys to human health.
A Bio Revolution
An ecology of 38 trillion microbes lives within each of us.
This is our microbiome—it expresses 100x more genes than our human cells and co-evolved with us over 2 million years1. Unlike our genome, the microbiome is dynamic, ever-responding to our environment and choices—revealing a novel pathway for well-being that radically evolves how we live and our paradigms of care.
As the modern world impacts human health and that of all living organisms, the microbiome moves us beyond prevention and treatment to a sustainable, systems-based future.
Early attempts to realize the potential of the microbiome have been limited by primitive tools, small data sets, and shallow sequencing. Utilizing advanced computational biology, microbial genomics, and ultra-deep sequencing, we construct proprietary data clouds to elucidate host-microbe interactions and provide unparalleled insight into the microbiome’s role in human health.
This insight, paired with our powerful commercialization engine, fuels our end-to-end platform to advance breakthrough research from discovery to real-world impact.
Early attempts to realize the potential of the microbiome have been limited by primitive tools, small data sets, and shallow sequencing. Utilizing advanced computational biology, microbial genomics, and ultra-deep sequencing, we construct proprietary data clouds to elucidate host-microbe interactions and provide unparalleled insight into the microbiome’s role in human health.
This insight, paired with our powerful commercialization engine, fuels our end-to-end platform to advance breakthrough research from discovery to real-world impact.
Human-First Discovery
Our platform is fueled by large, multi-omics, controlled data sets and human-centric testing models.
Programs
Our research programs drive product innovation in multiple categories to optimize the development and maturation of the human microbiome from birth through healthy aging.
The first three years of life are a critical developmental window for humans, encompassing microbiome seeding, immune system maturation, and metabolic priming. Our suite of microbiome-centric solutions seeds the appropriate bacteria at the optimal time to establish a strong symbiotic host-microbiome relationship from the beginning of life.
Key Scientists
Eran Segal Ph.D, The Weizmann Institute of Science
Cezmi Akdis, MD, University of Zurich (SIAF)
Jacques Ravel, PhD, University of Maryland School of Medicine
Applications
Gastrointestinal Health
Dermatological Health
Pipeline
Our translational work culminates in the discovery and validation of novel applications of prebiotics, probiotics, postbiotics, and synbiotics for key windows of intervention throughout life.
Gut Health–Brain Health | Infant
Consumer Applications
Consumer Application:GBH-01 • Prebiotic
Gut Health–Skin Health | Infant
Consumer Applications
Consumer Application:GSH-01 • Prebiotic + Probiotic + Postbiotic
Skin Health | Infant
Consumer Applications
Consumer Application:SH-01 • Prebiotic
Gut Health | Pediatric
Consumer Applications
Consumer Application:PDS-08® • Synbiotic for intermittent constipation, immune, & respiratory health
Gut Health–Brain Health | Pediatric
Consumer Applications
Consumer Application:GBH-01 • Prebiotic
Skin Health | Pediatric
Consumer Applications
Consumer Application:SH-01 • Prebiotic
Nutrition | Pediatric
Consumer Applications
Consumer Application:PN-01 • Prebiotic
Gut Health | Adult
Consumer Applications
Consumer Application:DS-01® • Synbiotic delivering broad-spectrum probiotic species for whole-body health
Gut Health–Brain Health | Adult
Consumer Applications
Consumer Application:GBH-01 • Prebiotic
Skin Health | Adult
Consumer Applications
Consumer Application:SH-01 • Prebiotic
Consumer Application:SH-02 • Prebiotic + Postbiotic
Vaginal Health | Adult
Consumer Applications
Consumer Application:VH-01 • Synbiotic
Consumer Application:VH-02 • Abiotic
Therapeutic Applications
Therapeutic Application:VHT-01 • Live biotherapeutic for cervical cancer prevention
Therapeutic Application:VHT-02 • Live biotherapeutic for recurrent UTI
Metabolic Health | Adult
Consumer Applications
Consumer Application:MH-01 • Synbiotic
Nutrition | Adult
Consumer Applications
Consumer Application:PN-01 • Prebiotic
Gut Health | Aging
Consumer Applications
Consumer Application:GH-02 • Synbiotic
Metabolic Health | Aging
Consumer Applications
Consumer Application:MH-01 • Synbiotic
Environmental Health
Born from our belief that health is not just human, we founded SeedLabs to advance emergent research and microbial innovations to address some of the greatest environmental challenges induced by human activity.
George Church (Ph.D)
Seed Health Scientific Board
As we delve deeper into the untapped world of microbial life, we uncover transformative solutions that can significantly improve planetary health and pave the way for a more sustainable future.
Press
View All
One billionth the size the point of a pen
microscopic but on a macro level within
And unfurled the swirling cloud of light
A star city, a galaxy, with all its might.
GZA, The Spark
